IP Library Granted Patent US 10,722,718
Granted Patent B2
US 10,722,718 · App. 16/195,719 · Granted Jul 28, 2020

Systems and methods for treatment of dry eye

Inventors: Douglas Michael Ackermann (San Francisco, CA); Daniel Palanker (Palo Alto, CA); James Donald Loudin (Houston, TX); Garrett Cale Smith (San Francisco, CA); Victor Wayne McCray (San Jose, CA); Brandon McNary Felkins (Half Moon Bay, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
A61N1/37205A61N1/3606A61N1/36046A61N1/36142A61N1/3756A61N1/3787A61N1/36057A61N1/37211
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,718
App. No.
16/195,719
Granted
Jul 28, 2020
Kind
B2
Abstract

A stimulation system stimulates anatomical targets in a patient for treatment of dry eye. The system may include a controller and a microstimulator. The controller may be implemented externally to or internally within the microstimulator. The components of the controller and microstimulator may be implemented in a single unit or in separate devices. When implemented separately, the controller and microstimulator may communicate wirelessly or via a wired connection. The microstimulator may generate pulses from a controller signal and apply the signal via one or more electrodes to an anatomical target. The microstimulator may not have any intelligence or logic to shape or modify a signal. The microstimulator may be a passive device configured to generate a pulse based on a signal received from the controller. The microstimulator may shape or modify a signal. Waveforms having different frequency, amplitude and period characteristics may stimulate different anatomical targets in a patient.

Claims (19)

1. A method for treating a condition of an eye of a user, comprising:

positioning a flexible microstimulator adjacent to an anatomical target selected to produce lacrimation;

conforming a portion of the flexible microstimulator to an anatomical structure of the patient; and

delivering a stimulus to the anatomical target when the user depresses a button, the stimulus provided using an electrode of the micro stimulator to increase a volume of tears in the eye of the user without stimulating an ocular muscle.

2. The method of claim 1 wherein during the positioning step the flexible microstimulator is advanced adjacent into a region of a user skull to provide access to the anatomical target.

3. The method of claim 2 wherein the region of the skull is a sphenoid bone, an inferior orbital fissure, a portion of the nasal-maxillary area or a nasal cavity.

4. The method of claim 1 wherein the delivering the stimulus step does not activate a pain sensation in the user.

5. The method of claim 1 wherein after the conforming step a rounded end of the electrode of the microstimulator is on or adjacent to the anatomical target selected to produce lacrimation.

6. The method of claim 1 , wherein the stimulus has a pulse amplitude, a pulse width, and a pulse frequency, and wherein one or more of the pulse amplitude, pulse width, or pulse frequency is varied over the user treatment period.

7. The method of claim 6 , wherein the amplitude of the stimulus is ramped from a low amplitude to a higher amplitude over the user treatment period.

8. The method of claim 6 , wherein the amplitude of the stimulus is ramped from a high amplitude to a lower amplitude over the user treatment period.

9. The method of claim 6 , wherein the pulse width of the stimulus is ramped from a low pulse width to a higher pulse width over the user treatment period.

10. The method of claim 6 , wherein the pulse width of the stimulus is ramped from a high pulse width to a lower pulse width over the user treatment period.

11. The method of claim 1 further comprising: performing the delivering a stimulation step for between 1 second and 15 minutes after the user depresses a button.

12. The method of claim 1 further comprising: performing the delivering a stimulation step for between 5 seconds and 30 seconds after the user depresses a button.

13. The method of claim 1 , wherein the stimulus includes a current having a pulse amplitude between about 500 μA and about 25 mA.

14. The method of claim 1 , wherein the stimulus has a pulse frequency between about 2 Hz and about 200 Hz.

15. The method of claim 1 , wherein the stimulus has a pulse width between about 50 μs and about 2700 μs.

16. The method of claim 1 , wherein the anatomical target is one or more nerves that innervates lacrimal gland tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2020
From: ACKERMANN, DOUGLAS MICHAEL; PALANKER, DANIEL; LOUDIN, JAMES DONALD; SMITH, GARRETT CALE; MCCRAY, VICTOR WAYNE; FELKINS, BRANDON MCNARY
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 053143/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: ACKERMANN, DOUGLAS MICHAEL; PALANKER, DANIEL; LOUDIN, JAMES DONALD; SMITH, GARRETT CALE; MCCRAY, VICTOR WAYNE; FELKINS, BRANDON MCNARY
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 052302/0001 →
Continuity (9)
Continuation 15828950 · Dec 1, 2017
Continuation 14816846 · Aug 3, 2015
Continuation 14561107 · Dec 4, 2014
Continuation 13298042 · Nov 16, 2011
Provisional Application 61414293 · Nov 16, 2010
Provisional Application 61433645 · Jan 18, 2011
Provisional Application 61433649 · Jan 18, 2011
Provisional Application 61433652 · Jan 18, 2011
Related Publication 20190290922A1 · Sep 26, 2019